Multi-purpose solution delivers potency of hydrogen peroxide in safe, efficacious product

Article

A multi-purpose solution for disinfecting contact lenses, based on a proprietary combination of alexidine dihydrochloride and polyquaternium-1 provided robust disinfection with a variety of soft contact lenses.

Those were the findings of a 6-month, double-masked, parallel group study of 270 patients that built upon 3-month results reported in a poster at the British Contact Lens Association.1, 2

Patients were randomly assigned to receive one of the two solutions according to a pre-determined schedule. Two patients were assigned to receive the alexidine dihydrochloride and polyquaternium-1 solution (the test solution) for every patient that was assigned to receive the polyquaternium-1 and myristamidopropyl dimethylamine solution (control).

The lenses were assessed for cleanliness by computer-measured light reflectance from the lens surface with dark field microscopy. The patients also were examined for corneal staining and asked to subjectively rate overall lens comfort.

Impact of adverse events

The researchers found no statistically significant differences between any of the five types of lenses cleaned with either of the two solutions. The only exception was a lower light reflectivity-indicating a cleaner lens-with the control solution on balafilcon A lenses, which was a statistically but not clinically significant difference. There was no difference between the two solutions in corneal staining change from baseline (p=0.320) and subjective overall lens comfort change from baseline (p=0.509).

Adverse events were more common in the control group than in the test group. At the 3-month visit, adverse events were reported in 11.8% of the patients using the control solution and 2.8% of the patients using the test solution. At the 6-month visit, adverse events were reported in 12.9% of the patients using the control solution and 3.4% of the patients using the test solution. These differences were statistically significant at both the 3-month (p=0.005) and 6-month (p=0.004) visits.

The adverse events were reported and classified by the principal investigators. There were a total of 6 events in the test group and 19 in the control group. These events included suspected viral conjunctivitis, corneal infiltrates, peripheral ulcers, giant papillary conjunctivitis, and corneal erosions. All the events were classified by etiology: related to the solution, of uncertain etiology, or not related to the solution. Many of the adverse events were reported to be of uncertain etiology.

"[The alexidine dihydrochloride and polyquaternium-1 test solution] is a highly effective dual-disinfectant soft lens care solution, with a kill rate exceeding the standard requirements with both panel organisms as well as clinical isolates," the researchers wrote. "It is therefore remarkable that this potent multi-purpose disinfecting solution has also been found to be gentle to ocular tissue and acceptably comfortable for patient use on a daily basis with all lenses, including silicone hydrogels."

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.